Literature DB >> 12914615

Pulmonary vein isolation for treatment of atrial fibrillation: recent updates.

Niranjan Seshadri1, Nassir F Marrouche, David Wilber, Douglas Packer, Andrea Natale.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12914615     DOI: 10.1046/j.1460-9592.2003.t01-1-00244.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


× No keyword cloud information.
  5 in total

1.  Use of a non-fluoroscopic catheter navigation system for pulmonary vein isolation.

Authors:  Mark A Wood; Paul J Christman; Richard K Shepard; Kenneth A Ellenbogen
Journal:  J Interv Card Electrophysiol       Date:  2004-04       Impact factor: 1.900

2.  Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.

Authors:  Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Shunichi Higashiya; Hiroshi Kawamura; Masaaki Murakami; Shigeshi Kamikawa; Satoshi Hirohata; Shozo Kusachi
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

3.  Ablation of "Background Tachycardia" in Long Standing Atrial Fibrillation: Improving the Outcomes by Unmasking a Residual Atrial Fibrillation Perpetuator.

Authors:  José Carlos Pachón-M; Enrique I Pachón-M; Tomas G Santillana P; Tasso Julio Lobo; Carlos Thiene C Pachón; Juán Carlos Pachón-M; Remy Nelson Albornoz V; Juán Carlos Zerpa A; Felipe Ortencio; Mauricio Arruda
Journal:  J Atr Fibrillation       Date:  2017-08-31

4.  Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence.

Authors:  Shunichi Higashiya; Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Hiroshi Kawamura; Masaaki Murakami; Shigeshi Kamikawa; Issei Komatsubara; Shozo Kusachi
Journal:  Open Heart       Date:  2017-03-27

5.  Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.

Authors:  Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Shunich Higashiya; Hiroshi Kawamura; Masaaki Murakami; Shigeshi Kamikawa; Issei Komtasubara; Shozo Kusachi
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.